Our Services
At Rybalka Consulting, we provide expert services tailored for the rare neuromuscular disease and therapeutics industry. Our services help patient organisations, pharmaceutical companies, biotech firms, and healthcare innovators identify growth opportunities, mitigate risks, and enhance research and development efforts. By leveraging our network and experience, we facilitate informed discussions for coalition-building and offer a range of professional services.
-
We analyze and provide strategic advice on therapeutic development pipelining, pre-/clinical trial design, regulatory aspects, funding opportunities, and collaborative team building.
-
We create specialized expert opinion content on inherited and acquired neuromuscular diseases, particularly those related to metabolic errors, for top pharmaceutical and biotech companies in Europe, the U.S., Asia, and Australia. As an end-to-end service, we can also present your R & D efforts at relevant conferences, workshops and summits around the world.
-
We offer high calibre scientific and medical writing services including grants, regulatory submissions, disease and therapeutic landscape reviews, journal papers, oral presentation decks, conference posters, web content and media communications.
